Envoy Medical Advances Acclaim Cochlear Implant Trial
WHITE BEAR LAKE, Minn., July 21, 2026 Envoy Medical announced that all 56 patients enrolled in its pivotal clinical...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
WHITE BEAR LAKE, Minn., July 21, 2026 Envoy Medical announced that all 56 patients enrolled in its pivotal clinical...
LONE TREE, Colorado, July 13, 2026 Cochlear Limited, a global leader in implantable hearing solutions, has announced U.S. FDA...
WHITE BEAR LAKE, Minn., April 22, 2026 Envoy Medical, Inc. announced a major milestone in its pivotal clinical trial...
COPENHAGEN, November 6, 2025 — GN Store Nord A/S (GN) reported a strong Q3 2025 performance, achieving 1% organic...
